Class 'A' Ordinary Shares

Trinity Biotech plc

IDA Business Park, County Wicklow, L2, A98 H5C8

Item 2(a) of the Schedule 13D is hereby amended and restated in full as follows: This Amendment No. 6 is being filed jointly by MiCo IVD, AI n M net Ltd., a limited company incorporated in South Korea ("AI n M") and Joon Ho Lee (collectively, the "Reporting Persons"). AI n M beneficially owns all of the equity interests in MiCo IVD. Mr. Lee serves as the manager, chief executive officer and president of MiCo IVD. Certain information regarding each director and executive officer of AI n M is set forth on Annex B as filed with Amendment No. 5.

Item 2(b) of the Schedule 13D is hereby amended and restated in full as follows: The address of AI n M is 8F, 27 Hwangsaeul-ro 360beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea. The address of each of MiCo IVD and Mr. Lee is 85 Orchard Road, Skillman, New Jersey 08558.

Item 2(c) of the Schedule 13D is hereby amended and restated in full as follows: The principal business of AI n M is wholesale and retail trade. The principal business of MiCo IVD is investing in securities of the Issuer. The principal occupation of Mr. Lee is manager, chief executive officer and president of MiCo IVD.

Item 2(e) of the Schedule 13D is hereby amended and restated in full as follows: During the last five years, none the Reporting Persons, nor any person identified in Item 2(a), has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Item 2(f) of the Schedule 13D is hereby amended and restated in full as follows: AI n M was formed in South Korea. MiCo IVD was formed in Delaware, United States. Mr. Lee is a citizen of the United States.

Item 5(a) of the Schedule 13D is hereby amended and restated in full as follows: The aggregate number and percentage of the Ordinary Shares beneficially owned by each Reporting Person and, for each Reporting Person, the number of shares as to which there is sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition are set forth on rows 7 through 11 and row 13 of the cover pages of this Schedule 13D and are incorporated herein by reference. As of the date hereof, the Reporting Persons may be deemed to beneficially own 69,450,720 Ordinary Shares consisting of: (i) 2,237,969 ADSs, which represent 44,759,380 Ordinary Shares and (ii) 1,234,567 ADSs representing 24,691,340 Ordinary Shares issuable upon conversion of the Convertible Note. This represents an aggregate beneficial ownership of 17.0% of the Ordinary Shares, calculated on an as-converted basis assuming full conversion of the Convertible Note into ADSs. The percentage of beneficial ownership is based upon 383,881,600 Ordinary Shares reported to be outstanding by the Issuer as of March 15, 2025 in the Issuer's final prospectus filed pursuant to Rule 424(b)(3) on March 31, 2025 and the 24,691,340 Ordinary Shares represented by ADSs issuable upon conversion of the Convertible Note held by MiCo IVD. AI n M may be deemed to be the beneficial owner of the Ordinary Shares beneficially owned by MiCo IVD through its ownership interests in MiCo IVD. Mr. Lee may be deemed to be the beneficial owner of the Ordinary Shares beneficially owned by MiCo IVD through his position as manager, chief executive officer and president of MiCo IVD. Neither the filing of this Schedule 13D nor any of its contents shall be deemed to constitute an admission that AI n M or Mr. Lee is the beneficial owner of Ordinary Shares referred to herein for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, or for any other purpose, and AI n M and Mr. Lee expressly disclaim beneficial ownership of such shares, except to the extent of its or his pecuniary interest therein.

Item 5(b) of the Schedule 13D is hereby amended and restated in full as follows: The aggregate number and percentage of the Ordinary Shares beneficially owned by each Reporting Person and, for each Reporting Person, the number of shares as to which there is sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition are set forth on rows 7 through 11 and row 13 of the cover pages of this Schedule 13D and are incorporated herein by reference.

Item 5(c) of the Schedule 13D is hereby amended and restated in full as follows: Except as set forth in this Schedule 13D, none of the Reporting Persons nor, to the best knowledge of the Reporting Persons, any other person named in Item 2, has engaged in any transaction in Ordinary Shares during the past 60 days.